Skip to main content

Table 1 Baseline characteristics of 338 HCC patients

From: Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC

Variables

Total cohort

(nā€‰=ā€‰338)

BCLC 0/A HCC

(nā€‰=ā€‰205)

BCLC B/C HCC

(nā€‰=ā€‰133)

Age, yearsā€ 

52 (44ā€“66)

52 (44ā€“60)

52 (43ā€“60)

Male genderā€”

299 (88.5)

180 (87.5)

119 (89.5)

Positive HBsAgā€”

278 (82.2)

170 (82.9)

108 (81.2)

Total bilirubin, Ī¼mol/lā€ 

14.0 (13.4ā€“19.4)

13.9 (10.0ā€“19.6)

14.4 (10.6ā€“18.7)

Albumin, g/lā€ 

37.9 (35.1ā€“40.8)

38.0 (35.4ā€“41.0)

37.6 (34.0ā€“40.7)

ALT, U/lā€ 

36.1 (25.8ā€“52.0)

34.3 (24.7ā€“53.0)

37.9 (26.4ā€“51.0)

Prothrombin time, sā€ 

13.2 (12.0ā€“14.1)

13.2 (12.0ā€“14.1)

13.2 (12.1ā€“14.1)

INRā€ 

1.04 (0.95ā€“1.14)

1.04 (0.94ā€“1.14)

1.05 (0.95ā€“1.14)

Platelet count, Ɨā€‰109/lā€ 

155 (110ā€“205)

155 (110ā€“211)

154 (113.5ā€“201.5)

Maximum tumor size, cmā€ 

6.0 (4.2ā€“10.0)

6.0 (3.5ā€“9.2)

8 (5.0ā€“11.0)

Serum AFP, ng/mlā€”

ā€ƒā‰„ā€‰400

141 (41.7)

73 (35.6)

68 (51.1)

ā€ƒ<ā€‰400

197 (58.3)

132 (64.4)

65 (48.9)

CSPHā€”

56 (16.6)

34 (16.6)

22 (16.5)

ALBI scoreā€ 

āˆ’ā€‰2.460 (āˆ’ā€‰2.704ā€“ āˆ’ā€‰2.192)

āˆ’ā€‰2.518 (āˆ’ā€‰ā€‰2.719ā€“āˆ’ā€‰2.236)

āˆ’ā€‰2.399 (āˆ’ā€‰2.702ā€“āˆ’ā€‰2.136)

ALBI gradeā€”

ā€ƒ1

134 (39.6)

89 (43.4)

45 (33.8)

ā€ƒ2

198 (58.6)

114 (55.6)

84 (63.2)

ā€ƒ3

6 (1.8)

2 (1.0)

4 (3.0)

MELD score (range)

7 (6ā€“18)

7 (6ā€“18)

7 (6ā€“17)

MELD scoreā€”

ā€ƒā‰„ā€‰9

88 (26.0)

47 (22.9)

41 (30.8)

ā€ƒ<ā€‰9

250 (74.0)

158 (77.1)

92 (69.2)

Child-Pugh gradeā€”

ā€ƒA

308 (91.1)

190 (92.7)

118 (88.7)

ā€ƒB

30 (8.9)

15 (7.3)

15 (11.3)

ā€ƒC

0 (0)

0 (0)

0 (0)

BCLC stageā€”

ā€ƒ0

12 (3.6)

ā€“

ā€“

ā€ƒA

193 (57.1)

ā€“

ā€“

ā€ƒB

82 (24.3)

ā€“

ā€“

ā€ƒC

51 (15.1)

ā€“

ā€“

  1. HCC hepatocellular carcinoma, HBsAg hepatitis B surface antigen, ALT alanine aminotransferase, INR international normalized ratio, AFP Ī±-fetoprotein, CSPH clinically significant portal pressure, ALBI albumin-bilirubin, BCLC Barcelona Clinic Liver Cancer
  2. ā€ Values are median (interquartile range)
  3. ā€”Values are number (%)